Agenus Inc. (AGEN) vs Indaptus Therapeutics, Inc. (INDP)
A side-by-side comparison of Agenus Inc. and Indaptus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$7.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
INDP
Indaptus Therapeutics, Inc.
$2.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AGEN vs INDP
growth of $100 · dividends reinvested · last 10yAGEN -94.1% (-24.6%/yr)INDP -100.0% (-57.5%/yr)AGEN compounded faster over this window
Log scale — wide-divergence pair
AGEN INDP
AGEN vs INDP: by the numbers
- •AGEN is the larger company ($312M vs $293M market cap).
- •AGEN is profitable (69.34% net margin) while INDP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AGEN | INDP |
|---|---|---|
| P/E ratio | 2.83 | N/A |
| Forward P/E | 28.00 | N/A |
| P/S ratio | 2.35 | N/A |
| P/B ratio | N/A | 25.79 |
| EV / EBITDA | 8.16 | N/A |
Profitability
| Metric | AGEN | INDP |
|---|---|---|
| Gross margin | 29.63% | 0.00% |
| Operating margin | -18.00% | 0.00% |
| Net margin | 69.34% | 0.00% |
| ROE | N/A | -135.62% |
| ROIC | N/A | -129.90% |
Growth (annualized)
| Metric | AGEN | INDP |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | N/A |
| Total return CAGR (5Y) | -40.10% | -58.32% |
Frequently asked
- Is AGEN or INDP more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus INDP at 0.00%.
- How have AGEN and INDP total returns compared?
- Over the past 10 years, AGEN delivered -24.61% and INDP delivered -57.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROEIndaptus Therapeutics ROEAgenus operating marginIndaptus Therapeutics operating marginAgenus revenue growthIndaptus Therapeutics revenue growthAgenus free cash flowIndaptus Therapeutics free cash flow
Agenus & Indaptus Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.